Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mandelblatt

Showing results (151-160 of 192) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2014
Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901Vanessa B Sheppard, Leigh Anne Faul, George Luta, et al.
Annals of Internal Medicine|May 2, 2012
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of riskNicolien T van Ravesteyn, Diana L Miglioretti, Natasha K Stout, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2018
Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49Jeroen J van den Broek, Nicolien T van Ravesteyn, Jeanne S Mandelblatt, et al.
JAMA Network Open|January 20, 2026
Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the USOguzhan Alagoz, Yifan Lu, Eugenio Gil Quessep, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physiciansJeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
JAMA Network Open|November 20, 2023
Deficit Accumulation Index and Biological Markers of Aging in Survivors of Childhood CancerAnnaLynn M Williams, Jeanne S Mandelblatt, Mingjuan Wang, et al.
JAMA|January 16, 2024
Analysis of Breast Cancer Mortality in the US-1975 to 2019Jennifer L Caswell-Jin, Liyang P Sun, Diego Munoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2014
Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?Jeanne S Mandelblatt, Robert A Stern, Gheorghe Luta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 19, 2026
Cancer Treatment-Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age AccelerationXiaoxi Meng, Tiffany Eulalio, Kwangyeon Oh, et al.
JNCI Cancer Spectrum|March 22, 2021
Protective Effects of <i>APOE</i> ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer StudyKathleen Van Dyk, Xingtao Zhou, Brent J Small, et al.
Pageof 20

Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2014
Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901Vanessa B Sheppard, Leigh Anne Faul, George Luta, et al.
Annals of Internal Medicine|May 2, 2012
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of riskNicolien T van Ravesteyn, Diana L Miglioretti, Natasha K Stout, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2018
Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49Jeroen J van den Broek, Nicolien T van Ravesteyn, Jeanne S Mandelblatt, et al.
JAMA Network Open|January 20, 2026
Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the USOguzhan Alagoz, Yifan Lu, Eugenio Gil Quessep, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physiciansJeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
JAMA Network Open|November 20, 2023
Deficit Accumulation Index and Biological Markers of Aging in Survivors of Childhood CancerAnnaLynn M Williams, Jeanne S Mandelblatt, Mingjuan Wang, et al.
JAMA|January 16, 2024
Analysis of Breast Cancer Mortality in the US-1975 to 2019Jennifer L Caswell-Jin, Liyang P Sun, Diego Munoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2014
Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?Jeanne S Mandelblatt, Robert A Stern, Gheorghe Luta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 19, 2026
Cancer Treatment-Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age AccelerationXiaoxi Meng, Tiffany Eulalio, Kwangyeon Oh, et al.
JNCI Cancer Spectrum|March 22, 2021
Protective Effects of <i>APOE</i> ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer StudyKathleen Van Dyk, Xingtao Zhou, Brent J Small, et al.
Pageof 20